Opharmic's expertise lies in developing advanced ultrasound platforms that provide precise, non-invasive solutions to some of the most pressing challenges in medicine.
Current Team Size
Years of R&D
Technology Platforms
Patents
Invasive and burdensome procedures severely restrict patient adherence, access to care, and optimal outcomes across drug delivery, chronic disease management, and emerging therapies.
Invasive Delivery Methods
Drug Adsorption Barriers
Raising Epidemic
Patient Access to
Novel Innovations